本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protagonist Therapeutics Inc

150.59
-4.1300-2.67%
成交量:66.45萬
成交額:1.01億
市值:97.44億
市盈率:146.20
高:157.98
開:155.84
低:150.09
收:154.72
52周最高:160.81
52周最低:54.50
股本:6,470.83萬
流通股本:6,316.60萬
量比:1.25
換手率:1.05%
股息:- -
股息率:- -
每股收益(TTM):1.03
每股收益(LYR):-2.0500
淨資產收益率:10.98%
總資產收益率:4.55%
市淨率:11.58
市盈率(LYR):-73.46

資料載入中...

2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/08/05

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/08/05

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/08/05

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/08/05

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/08/05

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/08/05

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/08/05

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/08/05

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/08/05

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/08/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/05

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2026/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/06/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/18

重要事件披露

Form 8-K - Current report
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities